Hep C Drug Alert: New Meds Don't Mix with Statins!
Share
Follow Us
Cholesterol-Reducing Statins, Other Meds to Be Avoided With Hep C Protease Inhibitors
March 1, 2012
Health care providers are being reminded not to prescribe certain cholesterol-reducing medications–notably members of the “statin” drug class–for people living with hepatitis C virus (HCV) using either Incivek (telaprevir) or Victrelis (boceprevir), according to a recent U.S. Food and Drug Administration (FDA)safety announcement.
The February 28 document, announcing various safety changes to package inserts for cholesterol-reducing medications, specifically notes that these hepatitis C protease inhibitors should never be taken with Mevacor (lovastatin).
Continue reading this entire article:
http://www.aidsmeds.com/articles/hepatitis_pis_interactions_1667_21995.shtml
